(Q37202263)

English

Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection

scientific article published on April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

feline immunodeficiency virus

object named as

feline immunodeficiency virus

1 reference

based on heuristic

inferred from title

author name string

J E Fogle

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

W A Tompkins

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

B Campbell

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

D Sumner

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

M B Tompkins

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

1 April 2011

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Veterinary Internal Medicine

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

25

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

413-418

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

2008 American Association of Feline Practitioners' feline retrovirus management guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Transmission and immunopathogenesis of FIV in cats as a model for HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

In vivo lymphocyte tropism of feline immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Zidovudine toxicity to cats infected with feline leukemia virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

6 September 2017

Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

26 June 2018

Feline immunodeficiency virus: a neurotropic lentivirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

26 June 2018

Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

26 June 2018

CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Low-dose interferon-alpha treatment for feline immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Development of clinical disease in cats experimentally infected with feline immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785110

3 September 2018

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2011.0699.X

21 January 2018

Toxicity associated with high dosage 9-[(2R,5R-2,5-dihydro-5-phosphonomethoxy)-2-furanyl]adenine therapy and attempts to abort early FIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1939-1676.2011.0699.X

21 January 2018

Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of diseased, FIV-seropositive field cats with azidothymidine (AZT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1939-1676.2011.0699.X

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

release_yzwugmsrhvfiteia62wakcmkzi

1 reference

https://api.fatcat.wiki/v0/release/yzwugmsrhvfiteia62wakcmkzi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37202263&oldid=1839079561"